NHS-Modified MMAF (TFA)
NHS-Modified MMAF (intermediat 210) TFA is an intermediate which can be used for producing the anti-mesothelin binder-agent conjugates (ADCs) [1].
Product Specifications
UNSPSC
12352203
Target
Drug-Linker Conjugates for ADC
Related Pathways
Antibody-drug Conjugate/ADC Related
Field of Research
Cancer
Purity
96.03
Smiles
O=C(N1CCCCO1)[C@@H](NC([C@H](C)[C@H]([C@@]2([H])N(CCC2)C(C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C([C@H](C(C)C)NC([C@H](C(C)C)N(C)CCCCCC(ON3C(CCC3=O)=O)=O)=O)=O)=O)OC)=O)CC4=CNC5=CC=CC=C45.OC(C(F)(F)F)=O
Molecular Formula
C57H87F3N8O14
Molecular Weight
1165.34
References & Citations
[1]Lerchen HG, et, al. Novel binder-drug conjugates (adcs) and their use. WO2012143499A2.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
ADC Related
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15134655 1 Vial
Lentiviral mouse Vmn2r9 shRNA (UAS) - Lentiviral mouse Vmn2r9 shRNA (UAS, iRFP) (100)
Ask
View Details 
